Ecofibre Limited Stock price

Equities

EOF

AU0000040057

Food Processing

Market Closed - Australian S.E. 10:30:55 2024-03-27 pm EDT 5-day change 1st Jan Change
0.09 AUD -5.26% Intraday chart for Ecofibre Limited -9.09% -43.75%
Sales 2022 30.22M 19.69M Sales 2023 32.51M 21.19M Capitalization 70.51M 45.95M
Net income 2022 -14M -9.12M Net income 2023 -39M -25.42M EV / Sales 2022 2.63 x
Net Debt 2022 12.46M 8.12M Net Debt 2023 19.74M 12.87M EV / Sales 2023 2.78 x
P/E ratio 2022
-4.53 x
P/E ratio 2023
-1.77 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 48.47%
More Fundamentals * Assessed data
Dynamic Chart
1 day-5.26%
1 week-9.09%
Current month-10.00%
1 month+3.45%
3 months-35.71%
6 months-52.63%
Current year-43.75%
More quotes
1 week
0.09
Extreme 0.09
0.11
1 month
0.08
Extreme 0.08
0.11
Current year
0.08
Extreme 0.08
0.16
1 year
0.08
Extreme 0.08
0.35
3 years
0.08
Extreme 0.08
1.26
5 years
0.08
Extreme 0.08
3.90
10 years
0.08
Extreme 0.08
3.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 21-06-30
Director of Finance/CFO - 15-12-31
Chief Tech/Sci/R&D Officer - 18-06-30
Members of the board TitleAgeSince
Director/Board Member - 22-08-31
Chief Executive Officer 59 21-06-30
Director/Board Member 67 21-03-03
More insiders
Date Price Change Volume
24-03-27 0.09 -5.26% 115
24-03-27 0.095 0.00% 6,438
24-03-26 0.095 -5.00% 5,910
24-03-25 0.1 +11.11% 172,553
24-03-22 0.09 -9.09% 34,491

Delayed Quote Australian S.E., March 27, 2024 at 10:30 pm EDT

More quotes
Ecofibre Limited is engaged in researching, producing, and selling sustainable polymers and natural materials, natural health care, plant-based foods and genetics. It also owns interest in pharmaceutical business that is developing treatments for malignant and non-malignant gynecological diseases. Its segments include Hemp Black, Ananda Health, Seed, Ecofibre Corporate, and EOF Bio. The Hemp Black segment is engaged in the production and sale of yarn and textile products in the United States. The Ananda Health segment is engaged in the production and sale of hemp related and other nutraceutical products in the United States and Australia. The Seed segment is engaged in growing and sale of hemp seed genetics. The Ecofibre Corporate segment includes group corporate functions and some of the research and development activities of the group. The EOF Bio segment is engaged in researching and commercializing gynecological and other pharmaceutical treatments using hemp derived cannabinoids.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Ecofibre Limited - Australian S.E.